Inactive Instrument

Other languages New Age Farm Inc Canadian Securities Exchange

Equities

CA64157D1087

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Mydecine Innovations Closes Partial Debt Settlement	Feb. 23
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	Feb. 02
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Mydecine Innovations Group Inc. Appoints John Ross as Corporate Secretary	23-07-21
Mydecine Innovations Group Appoints Todd Heinzl to the Board of Directors	23-05-29
Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Mydecine Innovations Group Inc. Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting Emp Analogues	23-04-24
Mydecine Innovations Group Inc. Auditor Raises 'Going Concern' Doubt	23-03-30
Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
Pangenomic Health Inc. completed the acquisition of Mindleap Health Inc. from Mydecine Innovations Group Inc. (OTCPK:MYCO.F).	22-12-08
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Mydecine Innovations Group Inc. Announces Board Changes	22-08-29
Mydecine Innovations Group Inc. Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting Mdma Analogs	22-08-29
Mydecine Innovations Group Inc. Announces Board Changes	22-08-19
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Mydecine Innovations Group Inc. Announces Resignation of Directors	22-08-12
Mydecine Files Full Patent Application Covering Myco-006 Family of Novel Short-Acting Mdma Analogs	22-07-19
Mydecine Innovations Group Announces U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation	22-06-17
Mydecine Innovations Group Inc. Announces Board Changes	22-06-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages New Age Farm Inc Canadian Securities Exchange

Equities

CA64157D1087

Other languages

Filters